Introduction
The current economic climate and the impacts posed on the trade and logistics industry has affected almost every part of the world, by the increased restrictions and outweighed immediate economic impacts. Further, it is evident from the market studies of different companies that Brexit effects in the overall economic harm posed to the organizations has been immense in recent times.
Summary of the project brief
The companies that had been affected by the Post Brexit introduction of laws and regulations, constitutes a large sector of the supply and logistics industry which involves the transaction of goods, import and export of supplies of a number of small medium industries. The project module can be inferred to the company regulations of AstraZeneca (UK), which is a world renowned pharmaceutical company and has faced serious legal and logistics challenges after the introduction of Post Brexit laws in travel of goods and shipping. The main objectives of the company has now incorporated, identification of manufacturers for storage and distribution of goods, their production from the EU factory outlets, assessment of the implications of the finished goods from UK and their respective distribution, which would be further followed by documentation of potential goods for the enhancement of the supply chain in the surplus maintenance of the goods.
Issues and challenges regarding the business operations
In anticipation of the diverging rules that have emerged after the Post Brexit period, posed to the UK companies, the pharmaceutical companies like AstraZeneca have been found to be more worried regarding the transaction of pharmaceutical goods from the companies end due to the reinforcements of laws after the Post-Brexit period.
The challenges that are faced by the company during this period were;
- Imposition of border checks
- Restrictions in dispersion of manufactured goods
- Logistical challenges for travel and shipping of goods
- Limitations in the export of raw goods
- Inability to provide finished goods and return of favorable stocks
Outcomes of the project module
The delays in distribution due to restrictions in the dispersion of manufacturing have partially disrupted the entire procedures of successful logistics and supply chain operations for the UK companies. According to the studies done by Roscoe et al. (2020), it has been reported that the UK companies have been observed to stockpiles of goods prior to Brexit for minimizing the risks after the introduction of the law. The manufacturers have found it tough to handle the complexities of the emergency situation due to the lack of effective strategies for overcoming the crisis period. This also determines that the manufacture and the supply wing of the companies are an evolving area of businesses that needs to remain in compliance with the satisfaction of the customers. Furthermore, new trade rules and effective planning might help avoid large downfalls in the company name and brand value.
Approaches of the project
Research studies done by Milne et al. (2020), on the post Brexit effects on the companies worldwide, especially focusing on the UK source companies suggests that the Brexit has been observed to have complicated the cross-border relationships of many companies like AstraZeneca. As many of the sectors of the economy found themselves unprepared for new regulations, hence introduction of planning’s is required for the sustenance of companies based on benefit approaches for supporting growth of the EU and UK operations. Creation of sustainable supply chains for ensuring timely deliveries of goods may be an accurate approach regarding the project module.
Gantt chart
Conclusion
With the increase in the uncertainties related to the sustenance of the manufacturing and supply chain efficacy, UK companies have found it complex enough to satisfy the administrative burdens. The provision and new policies requires appropriate jurisdictions having new rules which would relate to the socio-environmental protection, taxation leniencies, governmental subsidies for business and social and cultural issue address of worker rights for help responses in times of crisis.
References
Milne-Ives, M., Lam, C., van Velthoven, M. and Meinert, E. (2020). The impact of brexit on the pharmaceutical supply chain of the United Kingdom: scoping review protocol. JMIR Research Protocols, 9(9), p.e17684.
Roscoe, S., Skipworth, H., Aktas, E. and Habib, F. (2020). Managing supply chain uncertainty arising from geopolitical disruptions: evidence from the pharmaceutical industry and brexit. International Journal of Operations & Production Management.
write